Inactive Instrument

Singapore O&G Ltd.

Equities

1D8

SG1DG2000005

Healthcare Facilities & Services

Singapore O&G Ltd. Announces Resignation of Lee Keen Whye as Executive Director

December 30, 2021 at 03:18 pm IST

The Board of Directors of Singapore O&G Ltd. announced the resignation of Dr. Lee Keen Whye as Executive Director of the Company with effect from December 31, 2021. Dr. Lee remains as the Specialist Medical Practitioner of the Group.

Latest news about Singapore O&G Ltd.

LYC Mother & Child Centre Sdn Bhd agreed to acquire 49% stake in LYC SOG Mother & Child Sdn Bhd from Singapore O&G Ltd. for MYR 4.5 million.	02/01	CI
Singapore O&G Delists from Bourse as NewMedCo Completes Acquisition of Dissenting Shareholders' Shares	17/22/17	MT
Singapore O&G to Delist from Singapore Exchange on June 17	15/22/15	MT
Singapore O&G Gets Regulatory Nod to Delist from Bourse	08/22/08	MT
Singapore O&G Sets Up New Subsidiary in Singapore	13/22/13	MT
Singapore O&G Ltd. Announces Incorporation of New Subsidiary	12/22/12	CI
Hanaan Health Group Ltd., Beh Suan Tiong, Heng Tung Lan, Lee Keen Whye, Joyce Lim Teng Ee and Choo Wan Ling completed the acquisition of Singapore O&G Ltd. from Heng Siok Hong Veronica, Wong Chui Fong, Anna, Lee Tian Loon, Lee Tian Yang, Lee Tian Mun, Lee Wen Yi, Lee Wai Chan, Choo Wan Mei and Kessler Investment Holding Limited.	04/22/04	CI
NewMedCo Extends Closing Date of Offer to Acquire Singapore O&G	18/22/18	MT
Singapore O&G Ltd. Proposes Tax Exempt (One-Tier) Final Dividend for the Financial Year Ended 31 December 2021	13/22/13	CI
NewMedCo's Ownership in Singapore O&G Reaches Nearly 88%	13/22/13	MT
Singapore O&G Issues Shares Under Performance Share Plan	25/22/25	MT
NewMedCo's Ownership in Singapore O&G Reaches Nearly 81%	25/22/25	MT
Hanaan Health Group Ltd., Beh Suan Tiong, Heng Tung Lan, Lee Keen Whye, Joyce Lim Teng Ee and Choo Wan Ling made an offer to acquire Singapore O&G Ltd. from Heng Siok Hong Veronica, Wong Chui Fong, Anna, Lee Tian Loon, Lee Tian Yang, Lee Tian Mun, Lee Wen Yi, Lee Wai Chan, Choo Wan Mei and Kessler Investment Holding Limited for approximately SGD 140 million.	08/22/08	CI
Singapore O&G Receives Voluntary Takeover Offer from Sponsor, Promoters	07/22/07	MT
Singapore O&G Ltd. Announces Executive Changes	28/22/28	CI
Singapore Shares End in Red; Singapore O&G Plummets 11% on 33% Drop in H2 2021 Profit	24/22/24	MT
Singapore O&G's H2 2021 Profit Plummets 32.5%; Shares Slip 9%	24/22/24	MT
Singapore O&G Ltd. Recommends One-Tier Tax Exempt Final Ordinary Dividend for Fiscal Year 2021	23/22/23	CI
Singapore O&G Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	23/22/23	CI
Singapore O&G Ltd. Announces Resignation of Lee Keen Whye as Executive Director	30/21/30	CI
Singapore O&G : Joint Venture Establishes Marketing Unit	18/21/18	MT
Singapore O&G Ltd. Announces Executive Director Dr. Lee Keen Extends Medical Leave of Absence	27/21/27	CI
Singapore O&G : Logs Higher Profit, Revenue in H1 on Increased Patient Load	12/21/12	MT
Singapore O&G Ltd. Announces Interim Dividend for Financial Year 2021, Payable on 6 September 2021	11/21/11	CI
Tranche Update on Singapore O&G Ltd.'s Equity Buyback Plan announced on June 9, 2020.	11/21/11	CI

Chart Singapore O&G Ltd.

Duration

Period

More charts

Company Profile

Singapore O&G Ltd. is a Singapore-based healthcare service provider. The Company is engaged in delivering medical services to women's and children's health and wellness. The Company operates through four segments: Obstetrics and Gynaecology (O&G), Cancer-related, Dermatology and Paediatrics. Its O&G segment relates to general obstetrics, labor and delivery, general gynecology and surgery, female pelvic medicine, urogynecology and reconstructive surgery. Its Cancer-related segment relates to medical services for gynae-oncology, breast and general surgery. Its Dermatology segment relates to the provision of aesthetic dermatological procedures, dermatologic and laser surgery and general skin care. Its Paediatrics segment relates to the provision of general pediatrics and adolescent medical services.

Sector

Healthcare Facilities & Services

Calendar

08/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Sector Other Healthcare Facilities & Services

	1st Jan change	Capi.
HCA HEALTHCARE, INC.	+17.47%	82.59B
CVS HEALTH CORPORATION	-28.75%	69.86B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY	0.00%	26.5B
FRESENIUS SE & CO. KGAA	+2.67%	17.29B
LABCORP HOLDINGS INC.	-13.22%	16.61B
QUEST DIAGNOSTICS INCORPORATED	+2.08%	15.56B
NATERA, INC.	+74.94%	13.2B
REDE D'OR SÃO LUIZ S.A.	+1.95%	12.75B
TENET HEALTHCARE CORPORATION	+74.04%	12.6B

Other Healthcare Facilities & Services